Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 24, 2004
Up close and personal: molecular diagnostics in oncologyPhil D Rye, Harry Rittenhouse, Torgny Stigbrand
EJIFCC|September 30, 2016
Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)Carsten Stephan, Harry Rittenhouse, Xinhai Hu, et al.
Cancer Letters|February 17, 2007
Molecular markers for prostate cancerMark A Reynolds, Kumar Kastury, Jack Groskopf, et al.
Cancer Letters|November 25, 2010
PCA3: from basic molecular science to the clinical labJohn R Day, Matthias Jost, Mark A Reynolds, et al.
Anticancer Research|July 15, 2009
New markers and multivariate models for prostate cancer detectionCarsten Stephan, Harry Rittenhouse, Henning Cammann, et al.
The Journal of Urology|September 21, 2010
PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trialSheila M J Aubin, Jennifer Reid, Mark J Sarno, et al.
Urology|August 9, 2011
Prostate cancer gene 3 score predicts prostate biopsy outcome in men receiving dutasteride for prevention of prostate cancer: results from the REDUCE trialSheila M J Aubin, Jennifer Reid, Mark J Sarno, et al.
The Journal of Urology|March 21, 2008
PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillanceHiroyuki Nakanishi, Jack Groskopf, Herbert A Fritsche, et al.
The Journal of Urology|August 19, 2008
Predicting prostate cancer risk through incorporation of prostate cancer gene 3Donna Pauler Ankerst, Jack Groskopf, John R Day, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracyLori J Sokoll, William Ellis, Paul Lange, et al.
Pageof 2